Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
latest_posts
- 1
Geminid shooting stars: One of 2025's most exciting meteor showers begins tonight - 2Jennifer Lawrence and Josh Hutcherson to reprise their roles for new 'Hunger Games' movie 'Sunrise on the Reaping'
- 3Wolf bites woman in a shopping area in Germany's 2nd-biggest city
- 4Vacation destinations in America
- 5Students were skipping my astrophysics class to play video games – so I turned the class itself into a video game
- Watch comet C/2026 A1 plunge toward the sun online this week
- Trump says Cuba is 'ready to fall' after capture of Venezuela's Maduro
- Hezbollah fires over 600 times at Israel, IDF troops over last 24 hours
- Poll: Only 25% of Americans think Trump has 'followed through' on his promise to release the Epstein files
- Artemis 2 astronauts reveal adorable zero-g indicator 'Rise' | Space photo of the day for March 31, 2026
- Reporter's Notebook: The Post embeds with foreign armies visiting the IDF
- Earth’s magnetic field protects life on Earth from radiation, but it can move, and the magnetic poles can even flip
- We tasted one of the 10,000 Hershey's Dubai chocolate bars being resold on eBay. Is it worth the hype?
- ‘Democratizing space’ is more than just adding new players – it comes with questions around sustainability and sovereignty
